ID

39158

Descrizione

Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy; ODM derived from: https://clinicaltrials.gov/show/NCT02221583

collegamento

https://clinicaltrials.gov/show/NCT02221583

Keywords

versioni (1)
  1. 06/12/19 06/12/19 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

6 dicembre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility End Stage Renal Disease NCT02221583

Inglese

Eligibility End Stage Renal Disease NCT02221583

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. female or male patient aged > 18 years old.
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
2. esrd patient (on dialysis or preemptive) who is a potential candidate for kidney transplantation
Descrizione

Kidney Failure, Chronic | Dialysis | Patient Appropriate Kidney Transplantation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0022661
UMLS CUI [2]
C0011946
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C1548787
UMLS CUI [3,3]
C0022671
3. undergone laparoscopic sleeve gastrectomy procedure > 3 months prior to enrollment.
Descrizione

Laparoscopic sleeve gastrectomy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1960816
4. subjects have signed and dated the informed consent to participate in the study.
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients taking a drug known to interact with astagraf xl, prograf®, or mmf.
Descrizione

Pharmaceutical Preparations Interaction Astagraf XL | Pharmaceutical Preparations Interaction Prograf | Pharmaceutical Preparations Interaction MMF

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0687133
UMLS CUI [1,3]
C3666776
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0687133
UMLS CUI [2,3]
C0678125
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C0687133
UMLS CUI [3,3]
C0209368
2. patients that have an allergy to astagraf xl, prograf®, or mmf.
Descrizione

Hypersensitivity Astagraf XL | Hypersensitivity Prograf | Hypersensitivity MMF

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3666776
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0678125
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0209368
3. patients currently taking astagraf xl, prograf®, or mmf.
Descrizione

Astagraf XL | Prograf | MMF

Tipo di dati

boolean

Alias
UMLS CUI [1]
C3666776
UMLS CUI [2]
C0678125
UMLS CUI [3]
C0209368
4. post-surgical leak complication
Descrizione

Leak Complication Postoperative

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332234
UMLS CUI [1,2]
C0009566
UMLS CUI [1,3]
C0032790
5. patients failing to adhere to post laparoscopic sleeve gastrectomy follow-up recommendations and clinic visits
Descrizione

Adherence failed Laparoscopic sleeve gastrectomy Follow-up | Adherence failed Clinic Visits

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1510802
UMLS CUI [1,2]
C0231175
UMLS CUI [1,3]
C1960816
UMLS CUI [1,4]
C3274571
UMLS CUI [2,1]
C1510802
UMLS CUI [2,2]
C0231175
UMLS CUI [2,3]
C0008952
6. patients with any severe medical condition requiring acute or chronic treatment that in the investigator's opinion would interfere with study participation.
Descrizione

Medical condition Severe Treatment required for | Medical condition Severe | Requirement Treatment chronic | Medical condition Interferes with Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332121
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205082
UMLS CUI [3,1]
C1514873
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C0205191
UMLS CUI [4,1]
C3843040
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C2348568
7. pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive laboratory test
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. currently taking or planning to initiate of any medications that could interfere with tacrolimus and/or mycophenolate blood levels, including over the counter (otc) medications, herbal supplements, grapefruit or grapefruit juice.
Descrizione

Pharmaceutical Preparations Interfere with Blood tacrolimus level | Pharmaceutical Preparations Interfere with Mycophenolate level | Drugs, Non-Prescription | Herbal Supplements | Grapefruit | GRAPEFRUIT JUICE

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C1271702
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C3669267
UMLS CUI [3]
C0013231
UMLS CUI [4]
C1504473
UMLS CUI [5]
C0995150
UMLS CUI [6]
C0452456
9. subjects who have been exposed to an investigational therapy within 30 days prior to enrollment or 5 half-lives of the investigational product, whichever is greater.
Descrizione

Exposure to Investigational Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0332157
UMLS CUI [1,2]
C0949266
Ritorna all'inizio della pagina

Similar models

Eligibility End Stage Renal Disease NCT02221583

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. female or male patient aged > 18 years old.
boolean
C0001779 (UMLS CUI [1])
Kidney Failure, Chronic | Dialysis | Patient Appropriate Kidney Transplantation
Item
2. esrd patient (on dialysis or preemptive) who is a potential candidate for kidney transplantation
boolean
C0022661 (UMLS CUI [1])
C0011946 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C1548787 (UMLS CUI [3,2])
C0022671 (UMLS CUI [3,3])
Laparoscopic sleeve gastrectomy
Item
3. undergone laparoscopic sleeve gastrectomy procedure > 3 months prior to enrollment.
boolean
C1960816 (UMLS CUI [1])
Informed Consent
Item
4. subjects have signed and dated the informed consent to participate in the study.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pharmaceutical Preparations Interaction Astagraf XL | Pharmaceutical Preparations Interaction Prograf | Pharmaceutical Preparations Interaction MMF
Item
1. patients taking a drug known to interact with astagraf xl, prograf®, or mmf.
boolean
C0013227 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
C3666776 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0687133 (UMLS CUI [2,2])
C0678125 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C0687133 (UMLS CUI [3,2])
C0209368 (UMLS CUI [3,3])
Hypersensitivity Astagraf XL | Hypersensitivity Prograf | Hypersensitivity MMF
Item
2. patients that have an allergy to astagraf xl, prograf®, or mmf.
boolean
C0020517 (UMLS CUI [1,1])
C3666776 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0678125 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0209368 (UMLS CUI [3,2])
Astagraf XL | Prograf | MMF
Item
3. patients currently taking astagraf xl, prograf®, or mmf.
boolean
C3666776 (UMLS CUI [1])
C0678125 (UMLS CUI [2])
C0209368 (UMLS CUI [3])
Leak Complication Postoperative
Item
4. post-surgical leak complication
boolean
C0332234 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
C0032790 (UMLS CUI [1,3])
Adherence failed Laparoscopic sleeve gastrectomy Follow-up | Adherence failed Clinic Visits
Item
5. patients failing to adhere to post laparoscopic sleeve gastrectomy follow-up recommendations and clinic visits
boolean
C1510802 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C1960816 (UMLS CUI [1,3])
C3274571 (UMLS CUI [1,4])
C1510802 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
C0008952 (UMLS CUI [2,3])
Medical condition Severe Treatment required for | Medical condition Severe | Requirement Treatment chronic | Medical condition Interferes with Study Subject Participation Status
Item
6. patients with any severe medical condition requiring acute or chronic treatment that in the investigator's opinion would interfere with study participation.
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,3])
C3843040 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C1514873 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0205191 (UMLS CUI [3,3])
C3843040 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C2348568 (UMLS CUI [4,3])
Pregnancy | Breast Feeding
Item
7. pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive laboratory test
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pharmaceutical Preparations Interfere with Blood tacrolimus level | Pharmaceutical Preparations Interfere with Mycophenolate level | Drugs, Non-Prescription | Herbal Supplements | Grapefruit | GRAPEFRUIT JUICE
Item
8. currently taking or planning to initiate of any medications that could interfere with tacrolimus and/or mycophenolate blood levels, including over the counter (otc) medications, herbal supplements, grapefruit or grapefruit juice.
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C1271702 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C3669267 (UMLS CUI [2,3])
C0013231 (UMLS CUI [3])
C1504473 (UMLS CUI [4])
C0995150 (UMLS CUI [5])
C0452456 (UMLS CUI [6])
Exposure to Investigational Therapy
Item
9. subjects who have been exposed to an investigational therapy within 30 days prior to enrollment or 5 half-lives of the investigational product, whichever is greater.
boolean
C0332157 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial